Reduced carcinogenic effects of aflatoxin in rats given phenobarbitone.
D000348:Aflatoxins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000818:Animals; D001711:Biotransformation; D001835:Body Weight; D002273:Carcinogens / Q000037:antagonists & inhibitors*; D004790:Enzyme Induction; D008099:Liver / Q000201:enzymology / Q000473:pathology; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000453:epidemiology / Q000401:mortality; D006899:Mixed Function Oxygenases / Q000378:metabolism; D009374:Neoplasms, Experimental / Q000139:chemically induced; D010634:Phenobarbital / Q000494:pharmacology*; D011230:Precancerous Conditions; D051381:Rats; D013997:Time Factors
D000348:Aflatoxins; D002273:Carcinogens; D006899:Mixed Function Oxygenases; D010634:Phenobarbital